nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

ReachMD Healthcare Image
RestartResume

The number of individuals diagnosed with AMD and RVO increases daily. Make sure you’re doing everything to prevent vision loss in these patients.

  • Overview

    Approximately 2 million individuals in the United States are living with age-related macular degeneration (AMD), and another 1.6 million are living with retinal vein occlusion (RVO). These numbers are increasing daily due to an aging population and prevalence of risk factors. There have been many advances in treatment, but what else can you be doing to prevent vision loss in your patients?

    In this activity, Dr. Emily Chew speaks with Drs. Neil Bressler, Joseph Coney, and Steven Ferrucci to examine the evidence around early diagnosis, referral, and treatment of AMD and RVO and the impact of these diseases on patients’ lives.

Facebook Comments

Register

We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free